National Repository of Grey Literature 2 records found  Search took 0.01 seconds. 
Thyroid Gland in Newborn
Krylová, Kateřina ; Bayer, Milan (advisor) ; Al Taji, Eva (referee) ; Hrstková, Hana (referee)
THYROID GLAND IN NEWBORN MUDr. Kateřina Krylová SUMMARY Normal thyroid gland function during pregnancy and in newborns is a basic condition for normal growth, development and neurologic status during childhood and adulthood. The thyroid function can be influenced by external factors (mainly iodine supplementation and maternal thyroid diseases) and by anatomic and functional development of the fetal thyroid gland. Thyroid gland begins to form from third to twelfth gestational week and fetal thyroid hormones are detectable after 12 weeks of gestation. Fetus is fully dependent on maternal thyroid hormones during the first half of pregnancy and on maternal iodine supplementation during the whole course of pregnancy. The Czech Republic is considered a country with sufficient iodine supply in the general population although pregnant women are a population group in risk of iodine deficiency. Maternal thyroid diseases and iodine deficiency can lead to more prominent disability in newborns with congenital hypothyroidism even when treated in time. The functioning screening of congenital hypothyroidism and timely treatment is effective protection of affected newborns. One part of the management of these newborns is causal diagnosis of the congenital hypothyroidism. We are able to distinguish between morphologic...
Pathophysiology of primary congenital and early-onset non-autoimmune hypothyroidism
Al Taji, Eva ; Lebl, Jan (advisor) ; Dvořáková, Marcela (referee) ; Jiskra, Jan (referee) ; Stárka, Luboslav (referee)
Background: Thyroid dysgenesis (TD) and thyroid dyshormonogenesis clinically manifest as permanent primary congenital hypothyroidism (CH) and only rarely as non-congenital, postnatal non-autoimmune hypothyroidism. As basic molecular events underlying the regulation of thyroid development, growth and function were clarified in the last decade, molecular pathogenesis of TD and dyshormonogenesis has been intensively studied. Candidate genes for TD and dyshormonogenesis had been described and their mutations were subsequently detected in several patients with non-syndromic and syndromic CH. Nevertheless, no systematic population-based phenotype-focused molecular genetic analysis had been performed and concerning TD, the data regarded only a few individual patients. Aim: The aim of this extensive study was to identify monogenic forms of TD and dyshormonogenesis in a population-based cohort of Czech patients mostly with CH. Systematic mutation screening was based on a detailed clinical information and phenotype description, and thus focused on clinically defined subgroups of patients matching the phenotypes of already known candidate gene mutations.

Interested in being notified about new results for this query?
Subscribe to the RSS feed.